Douglas McAllister

Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell.

Vyome Therapeutics, Inc. develops research-based dermatology pharmaceutical solutions. It also develops drugs for antibiotics-resistant acne and other pathogens through a pipeline of antibiotics that retard resistance development. The company was founded by Rajesh Sudhir Gokhale, Rajeev Mantri, Venkateswarlu Nelabhotla, and Shiladitya Sengupta in August 2010 and is headquartered in Princeton, NJ.

Sentrian, Inc. operates remote analytics and monitoring platform. The company was founded by Jack Kreindler, Dean Sawyer, Lance Myers, and Marty Kohn in August 2012 and is headquartered in Aliso Viejo, CA.

Part of Signant Health, Clintara LLC is a company that provides clinical trials services. The company is based in Boston, MA. The CEO of the company is Colin Bower. Clintara was acquired by Bracket Global LLC on June 22, 2015.

AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD.

Perceptive Advisors (Private Equity) (Perceptive Advisors) is a private equity subsidiary of Perceptive Advisors LLC founded in 1999 by Joseph Eric Edelman. The firm is headquartered in New York.

Xontogeny LLC operates biotech aggregator company. The firm offers entrepreneurs with guidance and operational support in drug and technology development. The company was founded by Christopher Nishan Garabedian and is headquartered in Boston, MA.

Zucara Therapeutics, Inc. develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people. The company is headquartered in Toronto, Canada.

Bioharmony Therapeutics, Inc. develops lysin-based antimicrobial therapeutics for patients with multi-drug resistant gram-negative bacterial infections. The company was founded Chandrabali Ghose in July 2016 and is headquartered in New York, NY.

Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck.

Forge Biologics, Inc. operates as a gene therapy development engine, focused on enabling access to life changing gene therapies. The firm is a viral vector gene therapy manufacturing and development company with the dual platform of CDMO capabilities and the development of proprietary gene therapy products. The company was founded by Timothy J. Miller and Jaysson Eicholtz and is headquartered in Columbus, OH.

Forge Biologics Holdings LLC engages in the provision of biotechnology services. The company is headquartered in Grove City, OH.

SynapseBio, Inc. is based in New York, NY. SynapseBio is focused on utilizing statistical and machine learning models. SynapseBio is a venture-backed Digital Health company founded within AlleyCorp. The company was founded by Haba Fonseca-Sabune, Jeff De Flavio, Kevin Ryan, Colin Bower, Nick Chedid, and Jeffrey de Flavio. The CEO is Colin Bower.